DJIA 17,042.90 -28.32 -0.17%
NASDAQ 4,493.39 -12.46 -0.28%
S&P 500 1,972.29 -5.51 -0.28%
market minute promo

ACTAVIS (NYSE: ACT)

241.28 -3.11 (-1.27%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ACT $241.28 -1.27%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $244.02
Previous Close $244.39
Daily Range $240.06 - $244.53
52-Week Range $136.52 - $249.94
Market Cap $63.8B
P/E Ratio 375.98
Dividend (Yield) $0.00 (0.0%)
Volume 1,666,243
Average Daily Volume 1,876,571
Current FY EPS $13.28

Sector

Healthcare

Industry

Drugs

ACTAVIS (ACT) Description

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products. Website: http://www.actavis.com/

News & Commentary

Is It Time to Buy Dividend Stock Teva Pharmaceutical Industries Ltd?

Teva Pharmaceutical shares have buckled under the pressure of generic Copaxone launches. Is the stock now attractively priced?

Shrewd investor Carl Icahn is killing it

Carl Icahn made a killing on eBay

AMGN, ACT And GILD, Pushing Drugs Industry Downward

Trade-Ideas: Actavis (ACT) Is Today's New Lifetime High Stock

Should Pfizer Inc. Buy Actavis plc?

Pfizer is in a bit of pickle when it comes to generating growth. Although the company is flush with cash, it doesn't have much in the way of major new drugs in the pipeline and has a mountain of cash locked up abroad. Here is one way Pfizer could solve these lingering problems.

Allergan and Salix Pharmaceuticals Up on Takeover Rumors - Analyst Blog

P&G Exits Pet Care; To Vend Europe Unit to Spectrum Brands - Analyst Blog

Actavis to keep selling Alzheimer's drug in U.S. for 60 days

Why Actavis (ACT) Stock Is Higher Today

Actavis (ACT) Marked As A Barbarian At The Gate

See More ACT News...

ACT's Top Competitors

ACT $241.28 (-1.27%)
Current stock: ACT
JNJ $106.59 (0.05%)
Current stock: JNJ
NVS $94.13 (0.61%)
Current stock: NVS
RHHBY $36.99 (0.24%)
Current stock: RHHBY